pe anti human cd80 (R&D Systems)
Structured Review

Pe Anti Human Cd80, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/Human+B7-1%2FCD80+PE-conjugated+Antibody/pmc02575605-82-7-15
Average 94 stars, based on 10 article reviews
Images
1) Product Images from "Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells"
Article Title: Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells
Journal: Arthritis Research & Therapy
doi: 10.1186/ar2475
Figure Legend Snippet: Comparison of the phenotypic profiles of DCLCs primed with or without IFIT4 over-expression. (a) Surface antigens of normal THP-1 cells were examined by flow cytometry. (b) To analyze the effect of IFIT4 on phenotypic changes of dendritic cell-like cells (DCLCs) during the process of differentiation, THP-1 cells were transfected with pEGFP-IFIT4 or pEGFP-C1; 36 hours later, cells were stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF; 50 ng/ml) and IL-4 (20 ng/ml) for 90 hours to generate DCLCs. These DCLCs primed with pEGFP-IFIT4 or pEGFP-C1 transfection were incubated with fluorochrome-conjugated monoclonal antibodies (mAbs) and the antigens of CD40, CD80, CD86, CD83, HLA-DR, CD14 and CD1a on the surface of those DCLCs were analyzed by flow cytometry. Appropriate fluorochrome or isotype control mAbs of each antibody species were used as negative controls. Shaded histograms represent isotype control antibodies. The thick line represents DCLCs primed with pEGFP-IFIT4 transfection, whereas the slender lines represent DCLCs primed with pEGFP-C1 transfection. All experiments were performed three times and a set of representative histograms was presented. IFIT4, interferon-induced protein with tetratricopeptide repeats 4.
Techniques Used: Comparison, Over Expression, Flow Cytometry, Transfection, Incubation, Bioprocessing, Control
Related Articles
Staining:Article Title: Sulforaphane Epigenetically Regulates Innate Immune Responses of Porcine Monocyte-Derived Dendritic Cells Induced with Lipopolysaccharide Article Snippet: .. Cells were stained with a mouse anti-human CD40 FITC Ab (clone G28.5, NB100-77786, Novus Biologicals), a Article Title: A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice. Article Snippet: RESEARCH ARTICLE | MARCH 22 2023 A Therapeutic Vaccine in Combination with Cyclic GMP–AMP Cures More Di erentiated Melanomas in Mice Md Masud Alam; ... et. al J Immunol (2023) 210 (9): 1428–1436. https://doi.org/10.4049/jimmunol.2200371 Related Content Therapeutic Vaccine (TheraVac) in combination with cGAMP cures more differentiated melanomas in mice J Immunol (May,2021) Development of a curative therapeutic vaccine (TheraVac) for the treatment of large established tumors J Immunol (May,2017) Development of a Curative Immunotherapeutic Strategy for the Treatment of Big Established CT26 Tumors J Immunol (May,2016) D ow nloaded from http://journals.aai.org/jim m unol/article-pdf/210/9/1428/1645175/ji2200371.pdf by guest on 05 April 2024 Flow Cytometry:Article Title: A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice. Article Snippet: RESEARCH ARTICLE | MARCH 22 2023 A Therapeutic Vaccine in Combination with Cyclic GMP–AMP Cures More Di erentiated Melanomas in Mice Md Masud Alam; ... et. al J Immunol (2023) 210 (9): 1428–1436. https://doi.org/10.4049/jimmunol.2200371 Related Content Therapeutic Vaccine (TheraVac) in combination with cGAMP cures more differentiated melanomas in mice J Immunol (May,2021) Development of a curative therapeutic vaccine (TheraVac) for the treatment of large established tumors J Immunol (May,2017) Development of a Curative Immunotherapeutic Strategy for the Treatment of Big Established CT26 Tumors J Immunol (May,2016) D ow nloaded from http://journals.aai.org/jim m unol/article-pdf/210/9/1428/1645175/ji2200371.pdf by guest on 05 April 2024 Blocking Assay:Article Title: A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice. Article Snippet: RESEARCH ARTICLE | MARCH 22 2023 A Therapeutic Vaccine in Combination with Cyclic GMP–AMP Cures More Di erentiated Melanomas in Mice Md Masud Alam; ... et. al J Immunol (2023) 210 (9): 1428–1436. https://doi.org/10.4049/jimmunol.2200371 Related Content Therapeutic Vaccine (TheraVac) in combination with cGAMP cures more differentiated melanomas in mice J Immunol (May,2021) Development of a curative therapeutic vaccine (TheraVac) for the treatment of large established tumors J Immunol (May,2017) Development of a Curative Immunotherapeutic Strategy for the Treatment of Big Established CT26 Tumors J Immunol (May,2016) D ow nloaded from http://journals.aai.org/jim m unol/article-pdf/210/9/1428/1645175/ji2200371.pdf by guest on 05 April 2024 |

